Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.

Area of Science:

• Parasitology
• Immunology
• Vaccinology

Background:

• Transmission-blocking vaccines (TBVs) are crucial for malaria control, but current candidates lack high efficacy.
• The Plasmodium falciparum ookinete surface protein P25 is a key target, yet its proper expression for vaccines is challenging.
• Whole-parasite vaccines present an alternative to subunit vaccines for achieving functional antibody titers.

Purpose of the Study:

• To evaluate the efficacy of a purified transgenic rodent-malaria parasite (PbPfs25DR3) expressing P. falciparum P25 as a whole-parasite TBV.
• To assess the anti-Pfs25 immune response and transmission-blocking activity in both laboratory and field settings.

Main Methods:

• Vaccination of rodents with purified PbPfs25DR3 ookinetes expressing P. falciparum P25.
• Assessment of anti-Pfs25 antibody responses and transmission-blocking efficacy in laboratory settings.
• Testing efficacy using field isolates of P. falciparum from infected individuals in Burkina Faso.

Main Results:

• Vaccination with PbPfs25DR3 induced potent anti-Pfs25 antibody responses.
• Significant transmission-blocking efficacy was observed in laboratory experiments.
• High efficacy (up to 93.3% and 97.1% reduction in transmission intensity) was demonstrated with field isolates of P. falciparum.

Conclusions:

• A whole-parasite vaccine using transgenic PbPfs25DR3 ookinetes is effective in blocking malaria transmission.
• This approach shows promise for developing a novel, effective malaria transmission-blocking vaccine.
• The strategy supports further development of whole-parasite TBVs for malaria elimination efforts.